UNION KOREA PHARM CO.,Ltd Logo

UNION KOREA PHARM CO.,Ltd

Develops and manufactures prescription drugs like antibiotics and analgesics for global markets.

080720 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
강원도 원주시 문막읍 문막공단길 246, 원주시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Union Korea Pharm Co., Ltd. is a pharmaceutical company specializing in the research, development, production, and sale of prescription drugs. The company manufactures a range of specialty medicines, including antibiotics, anti-inflammatory analgesics, and skeletal muscle relaxants. Its products are available in various formulations such as solid dosage forms, liquid injections, and powder injections. Union Korea Pharm operates under strict quality control and Good Manufacturing Practice (GMP) standards. While its primary market is South Korea, the company also engages in international business, aiming to provide total healthcare solutions as a comprehensive bio-company.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for UNION KOREA PHARM CO.,Ltd and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-16 00:00
Legal Proceedings Report
회생절차개시결정
Korean 8.0 KB
2025-09-16 00:00
Delisting Announcement
주권매매거래정지기간변경 (회생절차 개시결정)
Korean 5.4 KB
2025-09-15 00:00
Legal Proceedings Report
횡령ㆍ배임혐의진행사항
Korean 6.4 KB
2025-09-11 00:00
Capital/Financing Update
사채원리금미지급발생
Korean 8.7 KB
2025-09-10 00:00
Legal Proceedings Report
[기재정정]주요사항보고서(회생절차개시신청)
Korean 8.8 KB
2025-09-09 00:00
Legal Proceedings Report
주요사항보고서(회생절차개시신청)
Korean 5.5 KB
2025-09-09 00:00
Delisting Announcement
주권매매거래정지기간변경 (회생절차 개시신청)
Korean 5.4 KB
2025-09-02 00:00
Legal Proceedings Report
횡령ㆍ배임혐의진행사항
Korean 6.4 KB
2025-09-01 00:00
Legal Proceedings Report
횡령ㆍ배임혐의진행사항
Korean 7.5 KB
2025-09-01 00:00
Legal Proceedings Report
횡령ㆍ배임혐의진행사항
Korean 7.4 KB
2025-08-29 00:00
Legal Proceedings Report
횡령ㆍ배임혐의진행사항
Korean 7.1 KB
2025-08-29 00:00
Legal Proceedings Report
횡령ㆍ배임혐의진행사항
Korean 6.9 KB

Automate Your Workflow. Get a real-time feed of all UNION KOREA PHARM CO.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for UNION KOREA PHARM CO.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
bioMérieux Logo
Provides in vitro diagnostic solutions for clinical and industrial microbiology.
France BIM
BioPorto Logo
IVD company developing NGAL biomarkers for early acute kidney injury (AKI) risk assessment.
Denmark BIOPOR
Biosergen AB Logo
Developing novel antifungal drugs for life-threatening infections in immunocompromised patients.
Sweden BIOSGN
Bio Solution Co.,Ltd. Logo
Develops cell therapies for degenerative diseases and supplies bio-lab reagents for R&D.
South Korea 086820
Biosynex Logo
European manufacturer of rapid diagnostic tests for professionals and consumer self-tests.
France ALBIO
Biotest AG Logo
Develops plasma protein products & biotherapeutics for immunology, haematology & intensive care.
Germany BIO3
Biotika A.S. Logo
Biotech firm making penicillin & polymyxin B APIs for human/vet use, plus contract manufacturing.
Slovakia BSL
Bioton S.A. Logo
Develops and manufactures recombinant human insulin for global diabetes care solutions.
Poland BIO
BIOVENTIX PLC Logo
Develops high-affinity sheep monoclonal antibodies for global clinical diagnostic immunoassays.
United Kingdom BVXP
Bioversys N Logo
Develops novel therapeutics to combat antimicrobial resistance in life-threatening infections.
Switzerland BIOV

Talk to a Data Expert

Have a question? We'll get back to you promptly.